Armistice Capital, Llc - Mar 31, 2025 SCHEDULE 13G/A Report for BioXcel Therapeutics, Inc. Common Stock, $0.001 par value per share (BTAI)

Filing Manager: ARMISTICE CAPITAL, LLC
Reporting Manager: Armistice Capital, LLC
Security: BioXcel Therapeutics, Inc. Common Stock, $0.001 par value per share
Symbol: BTAI
Shares outstanding: 5.77M shares
Disclosed Ownership: 288K shares
Ownership: 4.99%
Form type: SCHEDULE 13G/A
Date filed: 5/15/2025, 03:33 PM
Date of event: Mar 31, 2025
Previous filing: Feb 14, 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Armistice Capital, LLC	4.99%	288K	0	288K	/s/ Steven Boyd	Steven Boyd - Managing Member
Steven Boyd	4.99%	288K	0	288K	/s/ Steven Boyd	Steven Boyd